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Differential involvement of Wnt signaling in Bmp regulation
of cancellous versus periosteal bone growth
Guangxu He1,2, Yu Shi2, Joohyun Lim2#, Teresita Bellido3, Jiangdong Ni1 and Fanxin Long2,4
Bone morphogenetic proteins (Bmp) are well-known to induce bone formation following chondrogenesis,
but the direct role of Bmp signaling in the osteoblast lineage is not completely understood. We have recently
shown that deletion of the receptor Bmpr1a in the osteoblast lineage with Dmp1-Cre reduces osteoblast
activity in general but stimulates proliferation of preosteoblasts speciﬁcally in the cancellous bone region,
resulting in diminished periosteal bone growth juxtaposed with excessive cancellous bone formation.
Because expression of sclerostin (SOST), a secreted Wnt antagonist, is notably reduced in the Bmpr1a-
deﬁcient osteocytes, we have genetically tested the hypothesis that increased Wnt signaling might mediate
the increase in cancellous bone formation in response to Bmpr1a deletion. Forced expression of human SOST
from a Dmp1 promoter fragment partially rescues preosteoblast hyperproliferation and cancellous bone
overgrowth in the Bmpr1a mutant mice, demonstrating functional interaction between Bmp and Wnt
signaling in the cancellous bone compartment. To test whether increased Wnt signaling can compensate for
the defect in periosteal growth caused by Bmpr1a deletion, we have generated compound mutants harboring
a hyperactive mutation (A214V) in the Wnt receptor Lrp5. However, the mutant Lrp5 does not restore
periosteal bone growth in the Bmpr1a-deﬁcient mice. Thus, Bmp signaling restricts cancellous bone accrual
partly through induction of SOST that limits preosteoblast proliferation, but promotes periosteal bone
growth apparently independently of Wnt activation.
Bone Research (2017) 5, 17016; doi:10.1038/boneres.2017.16; published online: 6 June 2017
INTRODUCTION
Originally discovered in bone, bone morphogenetic
proteins (Bmp) play essential roles in both embryogenesis
and postnatal tissue homeostasis in mammals.1–3 Bmp
proteins signal through the serine/threonine kinase recep-
tors including four type I receptors (Bmpr1a, Bmpr1b,
Acvrl1, Acvr1) and three type II receptors (Bmpr2, Acvr2a
and Acvr2b).4 Binding of dimeric BMP proteins to a hetero-
tetramer including two molecules of each receptor type
leads to phosphorylation and activation of the type I
receptor by the type II receptor with constitutively active
kinase activity.5 In the best characterized mechanism, the
type I receptors phosphorylate receptor Smads (Smad 1, 5,
and 8) which in turn recruit the common partner Smad4
and other nuclear factors to regulate gene expression.3,6–7
In alternative pathways, Bmp proteins have been shown to
activate TAK1-p38 and PI3K-Akt signaling axis.4,6,8–9 We
have recently provided evidence that Bmpr1a signaling
activates mTORC1 to regulate bone formation.10 Depend-
ing on the cellular context, Bmp may employ different
effectors to control various biological processes.
Mouse knockout studies have established the essential
role of Bmp in cartilage development. Deletion of Smad4
or a combination of Bmp ligands in the prechondrogenic
mesenchyme has established that a threshold level of Bmp
signaling via Smad4 is essential for chondrogenesis.11–13 In
addition, deletion of Bmpr1a and Bmpr1b, or Smad1 and 5
in chondrocytes causes severe chondrodysplasia.14–15
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Thus, Bmp signaling critically regulates multiple steps of
cartilage development.
Mouse genetic studies have also revealed the impor-
tance of Bmp signaling in the osteoblast lineage. Knockout
of Bmp2 in the limb mesenchyme (Prx1-Cre) greatly
diminishes the strength of long bones in postnatal mice
resulting in spontaneous fractures.16 Deletion of Bmpr1a or
Smad4 in mature osteoblasts (Og2-Cre) decreases
cancellous bone mass in young mice due to reduced
bone formation, but leads to more bone at an older age
due to less bone resorption.17–18 Remarkably, deletion of
Bmpr1a with either Col1-CreER or Dmp1-Cre markedly
increases cancellous bone mass, whereas deletion with
Dmp1-Cre also diminishes periosteal bone growth.10,19–21
We have further shown that Bmpr1a deletion with
Dmp1-Cre reduces osteoblast activity but stimulates
preosteoblast proliferation within the cancellous bone
region.10 On the other hand, others have reported
that Bmpr1a deletion with either Col1-CreER or Dmp1-Cre
increases Wnt signaling which in turn suppresses
osteoclastogenesis.19 Whether changes in Wnt signaling
contribute to the regulation of preosteoblast proliferation or
osteoblast activity by Bmp has not been determined.
Here we test the role of Wnt signaling in mediating Bmpr1a
function in osteoblast lineage cells. Forced expression of the
human sclerostin (SOST, a secreted Wnt antagonist) from a
Dmp1 promoter fragment partially rescued hyperprolifera-
tion of preosteoblasts in the Dmp1-Cre; Bmpr1af/f mice. In
contrast, expression of either SOST or a hyperactive form of
the Wnt co-receptor Lrp5 did not modify the reduced
osteoblast activity caused by the loss of Bmpr1a. Thus, Bmp
signaling regulates bone formation through both Wnt-
dependent and -independent mechanisms.
MATERIALS AND METHODS
Mouse strains
Dmp1-Cre,22 Bmpr1af/f,23 Dmp1-SOST24 and Lrp5A214V/+
(ref. 25) mouse strains are as previously described. The
mouse strains were maintained in a mixed genetic back-
ground of mostly C57BL6 and some 129. All analyses were
performed on sex-matched littermates including both
males and females at the age of 33 days (P33). All mice
were housed in a speciﬁc pathogen-free (SPF) barrier
facility managed by Washington University Department of
Comparative Medicine. The animals were group housed
with a 12-h light cycle (6:00–18:00) and fed standard chow
(PicoLabmouse diet 20, product number 5058). The Animal
Studies Committee at Washington University approved all
mouse procedures used in this study.
Morphological analyses of bones
X-ray radiography was performed with Faxitron X-ray system
(Faxitron X-ray Corp, Buffalo Grove, IL, USA) for 20-second
exposures at 25 kV. Micro-computed tomography (μCT 40,
Scanco Medical AG, Wayne, PA, USA) was performed on
the tibia or the femur. Both procedures were performed on
post-mortem tissues. Quantiﬁcation of the cancellous bone
was assessed by measuring 100 μCT slices (1.6mm)
immediately below the growth plate, whereas the total
metaphyseal bone mass was calculated by including both
cortical and cancellous bone in those μCT slices, both with
a threshold of 240. For cortical bone parameters, 50 μCT
slices (0.8mm) from locations as indicated in the text were
analyzed, with a threshold of 260. Other key parameters for
μCT scan acquisition are as follows: voxel size 10 μm3, X-ray
tube potential 55 kVp, X-ray intensity 145 μA, integration
time 300ms.26
Hematoxylin and eosin (H&E) was performed on parafﬁn
sections with the thickness of 6 μm, following overnight
ﬁxation with neutral buffered 10% formalin and decalciﬁca-
tion with 14% EDTA (pH 7.4) for 2 weeks at room
temperature with daily changes of solution. For dynamic
histomorphometry of postnatal mice, calcein (Sigma)
dissolved in water (pH 7.2–7.4 adjusted with NaOH) was
injected at 7.5mg·kg−1 body weight intraperitoneally at 7
and 2 days, respectively, prior to killing. Bones were ﬁxed in
70% ethanol, embedded in methyl-methacrylate and
sectioned at 10 μm. Histomorphometric parameters were
acquired with Bioquant Osteo II from three sections per
mouse and three mice for each genotype.
In vivo assays
For serum CTX-I assays, serum was collected through
retro-orbital bleeding from mice starved for 6 h, and
analyzed with the RatLaps ELISA kit (Immunodiagnostic
Systems, Ltd., Gaithersburg, MD, USA) according to man-
ufacturer's instructions. To collect serum, blood was col-
lected with heparinized micro-hematocrit capillary tubes
(22–362–566, Fisher Scientiﬁc, Pittsburgh, PA, USA), trans-
ferred to BD Microtainer SST Tubes (365967, Becton,
Dickinson and Company, Franklin Lakes, NJ, USA). The SST
tubes containing blood samples were then inverted ﬁve
times and let sit at room temperature for 30min to allow
clotting before centrifugation for 90 s.
EdU (Invitrogen, Carlsbad, CA, USA) dissolved in water
was injected intraperitoneally at 10 μg ·g−1 body weight at
4 h before collection. Frozen sections were subjected to
immunostaining for Osx (ab22552, Abcam, Cambridge,
MA, USA) and Alexa Fluor 647 conjugated goat anti-rabbit
secondary antibody (A21246, Invitrogen), followed by a
click reaction according to manufacturer’s instructions
(Click-iT EdU Alexa Fluor 488 Imaging Kit, Invitrogen). A non-
immune IgG (5415S, Cell Signaling Technology, Danvers,
MA, USA) was used as negative control. Images were
acquired with the Nikon C-1 confocal system.
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Western blots of bone proteins
For western blots of bone extracts, femurs and tibiae from
P33 mice were cleanly dissected with the epiphysis
removed. After removing the marrow by centrifugation,
bones were cut into small pieces and rinsed three times
with ice-cold PBS. Bone pieces were snap-frozen in liquid
nitrogen, pulverized at 2 000 r ·min−1 for 20 s using a Mikro-
Dismembrator (Sartorius, Gottingen, Germany) and then
lysed with RIPA buffer containing protease inhibitors
(cOmplete, cat# 11836145001, Roche, Basel, Switzerland)
and phosphatase inhibitors (PhosSTOP, cat# 04906845001,
Roche). Western blots were performed as previously
described and the signals detected with Clarity ECL
Substrate (Bio-Rad, Hercules, CA, USA).27 Western images
were captured with Chemidoc (Bio-Rad).
Immunostaining of sclerostin
Immununohistochemistry of sclerostin was performed as
follows. Long bone sections were deparafﬁnized, brieﬂy
incubated in 3% H2O2 in methanol and rinsed in deionized
water. The sections were ﬁrst blocked with 5% normal serum
and then incubated in biotinylated sclerostin antibody
(BAF1589, R&D Systems, Minneapolis, MN, USA) at 1:500 in
blocking solution. Streptavidin-HRP antibody and DAB
substrate kit (Life Technologies, Carlsbad, CA, USA) were
used according to manufacturer’s instructions. For negative
control, the primary antibody was omitted from the
procedure. For immunoﬂuorescence detection of both
human and murine sclerostin, a polyclonal antibody
(ab75914, Abcam), together with Alexa Fluor 647 conju-
gated goat anti-rabbit secondary antibody (A21246, Invitro-
gen), was used on frozen sections of the femur from P33
mice. A non-immune IgG (5415S, Cell Signaling Technology)
was used as negative control. For preparation of frozen
sections, dissected bones were ﬁxed with 4% PFA overnight
at room temperature and incubated in 14% EDTA for 3 days
with daily change of solution. The bones were then put in
30% sucrose overnight at 4 °C for cryoprotection and
embedded in optimal cutting temperature (OCT) (Tissue-
Tek, Torrance, CA, USA). Sections of 10 μm in thickness were
obtained with a Leica cryostat equipped with Cryojane
(Leica, Buffalo Grove, IL, USA), and kept at −20 °C until use.
Fluorescent images were captured with the Nikon C-1
confocal system.
Statistics
Statistical signiﬁcance was calculated with either Student’s
t-test, one-way analysis of variance (GraphPad Prism,
La Jolla, CA, USA) or two-way Factorial analysis of variance
for independent samples (vassarstats.net) as indicated in
ﬁgure legends.
RESULTS
Forced expression of SOST ameliorates cancellous but not
cortical bone phenotype in Bmpr1a-deﬁcient mice
As previous studies have implicated the regulation of SOST
expression by Bmp, we examined the protein level of SOST
in the bones of the Dmp1-Cre; Bmpr1af/f (CKO) mice.
Because we have previously analyzed the CKO mice at
33 days of age (P33), we conducted the current study at
the same age to ensure consistency.10 The Dmp1-Cre
transgene expresses Cre from a 9.6-kb Dmp1 promoter
sequence, and the Bmpr1af allele has the second exon
ﬂoxed and results in a complete loss of function when
excised by Cre. Immunohistochemistry conﬁrmed osteo-
cytes as the predominant cell type expressing SOST in both
cortical and cancellous bone of the control mice
(Bmpr1af/f) at P33 (Figure 1a, middle). In contrast, SOST
was barely detectable in the same cell type of the CKO
littermate (Figure 1a, right). Western blot analyses of protein
extracts from the long bones corroborated the virtual
absence of SOST in the CKO samples (Figure 1b). These
results therefore conﬁrm that SOST is markedly reduced in
the Bmpr1a-deﬁcient bones.
We next tested whether SOST downregulation was
responsible for the bone phenotypes in the CKO mice. To
this end, we took advantage of the Dmp1-SOST transgenic
mouse that expresses the human SOST cDNA from a Dmp1
regulatory sequence and therefore is expected to main-
tain SOST levels in osteocytes in the CKO mice. Previous
characterization of the Dmp1-SOST mouse indicated that
modest expression of SOST from the transgene reduced
cancellous bone mass without affecting overall bone
resorption.24 In our mating scheme, four relevant geno-
types were produced at an equal Mendelian ratio of 1/4
(Figure 2a). We ﬁrst imaged the littermate mice at P33 with
X-ray, and found that the bones of the Dmp1-SOST mice
were largely normal (SOST versus CTRL), but all CKO mice
presented similar abnormal bonemorphology regardless of
Dmp1-SOST (SOST;CKO versus CKO; Figure 2b). In particular,
the CKO and the SOST;CKO mice exhibited a smaller bone
diameter at the proximal metaphysis of the femur (red
arrow) and throughout the tibia when compared to the
control (CTRL) or SOST littermates (Figure 2b). Imaging and
quantiﬁcation of the cortical bone with μCT conﬁrmed that
the overall bone size (Tt. Ar) was smaller at the proximal
femur (red arrow) in the CKO and the SOST;CKO mice,
but the bone area (Ct. Ar) was normal, resulting in a
smaller medullary space (Ma. Ar) than CTRL or SOST
(Figure 2c and d). Thus, forced expression of SOST does
not rescue the cortical bone phenotype caused by
Bmpr1a deletion.
The X-ray images revealed that the cancellous bone
region in the SOST;CKO mice was consistently shorter and
less radiopaque than that in the CKO mice (Figure 2b,
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green line). We therefore examined the metaphyseal
region of the femur in more detail with μCT. We conﬁrmed
that the SOST mice had considerably less cancellous bone
than the CTRL littermate, as indicated by both 3D
reconstruction images and quantiﬁcation of the cancel-
lous bone parameters (Figure 3a and b). The reconstruction
images also revealed that both CKO and SOST;CKO mice
possessed much more bone than either CTRL or SOST
littermates, but the SOST;CKO mice exhibited considerably
more marrow space within the cancellous bone region
than the CKO mice (Figure 3a, asterisks). Due to the fact
that cancellous versus cortical bone could not be reliably
distinguished in the CKO and the SOST;CKO mice, we
measured the total metaphyseal bone mass across all four
genotypes. Such measurements detected no signiﬁcant
difference in BV/TV between CTRL and SOST mice,
indicating that the difference in cancellous bone between
the two was obscured by the inclusion of the cortical bone
(Figure 3c). However, the SOST;CKO mice had signiﬁcantly
less metaphyseal bone mass (BV/TV) than the CKO
littermate, although still more than CTRL or SOST
(Figure 3c). The SOST transgene also signiﬁcantly reduced
trabecular number (Tb. N) and increased trabecular
separation (Tb. Sp) in the CKO background. Overall, SOST
expression partially corrects the phenotype of high can-
cellous bone mass caused by Bmpr1a deletion.
Bmp signaling restricts preosteoblast proliferation partly
through SOST induction
We next investigated further the effect of SOST on the
cancellous bone phenotype. Serum CTX-I assays detected
Figure 1. Deletion of Bmpr1a reduces SOST expression in osteocytes. (a) Representative images from immunohistochemistry of SOST on
sections of the femur from littermate mice at P33. (b) Western blots with protein extracts from femurs and tibiae at P33. Each lane represents sample
from a separate mouse. β-actin used as loading control. BM, bone marrow; CKO, Dmp1-Cre; Bmpr1af/f; M.W., molecular weight markers; SOST,
sclerostin.
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no difference among all four genotypes, indicating that
suppression of bone resorption was unlikely to be the
main mechanism for the excessive bone mass caused by
Bmpr1a deletion, or the partial rescue by SOST (Figure 4a).
Histology of the femur conﬁrmed the presence of more
marrow space within the cancellous bone region of the
SOST;CKO than the CKO mouse (Figure 4b, “M”). However,
similar to the CKO littermates, the SOST;CKO mice showed
an accumulation of osteoblasts between the neighboring
trabeculae in areas devoid of bone marrow (Figure 4b,
arrow). In addition, SOST overexpression did not alter the
osteocyte density that was markedly increased by Bmpr1a
deletion (Figure 4c and d, CKO vs SOST;CKO). Likewise,
SOST did not modify the marked decrease in periosteal
osteoblast activity as determined by calcein double
labeling in the CKO background (Figure 4e and f, CKO vs
SOST;CKO). Immunoﬂuorescence staining with an antibody
recognizing both murine and human sclerostin indicated
that the protein was elevated in the osteocytes of both
cancellous and cortical bone in the SOST;CKO over the
CKO mice (Figure 5). It should be noted, however, that the
overall level of sclerostin in the SOST;CKO mice was still
lower than that in CTRL. This result is consistent with our
previous characterization that the Dmp1-SOST transgene is
expressed at a relatively low level. Nonetheless, these
results demonstrate that forced expression of SOST was
sufﬁcient to reduce cancellous bone formation in the
Bmpr1a-deﬁcient mice.
As we have previously shown that Bmpr1a deletion
stimulates proliferation of preosteoblasts to increase
cancellous bone formation, we next examined the effect
of SOST expression on cell proliferation with the EdU labeling
technique. The method detected a relatively low
proliferation index (~5% EdU+) among all cells within the
chondro-osseous junction in both wild-type and SOST mice
(Figure 6a and b, CTRL vs SOST). Double labeling with an
Figure 2. Forced expression of SOST does not modify bone diameters in Bmpr1a-deﬁcient mice. (a) Mating scheme. (b) X-ray radiography of the
hindlimb from littermate mice at P33. Arrows denote restricted region in the proximal femur speciﬁc to CKO and SOST;CKO mice. Lines indicate
expanded cancellous bone region. (c and d) μCT images (c) or quantiﬁcation (d) of cortical bone acquired at the regions marked by the arrows or the
equivalent regions in (b). *Po0.001, one-way ANOVA, n= 5 for CTRL and CKO, n= 6 for SOST, n= 7 for SOST;CKO. f, femur; ﬁ, ﬁbula; SOST,
sclerostin; t, tibia; μCT, micro-computed tomography.
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Osx antibody showed that the Osx+ preosteoblasts also
proliferated at relatively low rate in either wild-type or SOST
mice (Figure 6c and d, CTRL, SOST). However, Bmpr1a
deletion markedly increased the proliferation index among
either all cell or the Osx+ preosteoblasts at the chondro-
osseous junction (Figure 6b and d, CKO vs CTRL).
Importantly, the increased proliferation caused by Bmpr1a
deletion was notably reduced by SOST overexpression even
though the labeling index remained signiﬁcantly higher
than that in the CTRL or SOST mice (Figure 6b and d).
Statistical analyses with two-way analysis of variance
indicated a signiﬁcant effect of SOST overexpression
on Bmp1a deletion (interaction P-value o0.001). We
conﬁrmed the speciﬁcity of the Osx antibody, as a non-
immune IgG did not detect any positive cells (Figure 6e).
Thus, forced expression of SOST partially suppresses hyper-
proliferation of osteoblast precursors caused by Bmpr1a
deletion.
High bone mass allele of Lrp5 does not rescue periosteal
bone growth in Bmpr1a-deﬁcient mice
The data so far indicate that SOST downregulation does
not contribute to the periosteal growth defect caused by
Bmpr1a deletion. This result is expected as SOST generally
suppresses bone formation through inhibition of Wnt
signaling. We next tested whether hyperactivation of Wnt
signaling could overcome the deﬁcit in periosteal growth.
To this end, we utilized the Lrp5A214V/+ knock-in mouse that
expresses from the endogenous Lrp5 locus a mutant Lrp5
allele (A214V) that is known to increase Wnt signaling and
cause high bone mass (HBM) in humans and mice. We
generated littermate animals with or without the HBM Lrp5
allele expressed in either wild-type or Bmpr1a-deﬁcient
background (Figure 7a). X-ray imaging at P33 detected an
increase in the cortical thickness of the long bones in the
HBM mice over the control littermates (Figure 7b, CTRL vs
HBM). However, expression of the HBM allele did not rescue
Figure 3. Forced expression of SOST reduces cancellous bone mass in Bmpr1a-deﬁcient mice. (a) μCT 3D reconstruction images of the metaphyseal
region of distal femur in littermate mice at P33. Asterisk denotes marrow space. (b) μCT quantiﬁcation of cancellous bone in the distal metaphyseal
region of the femur. *Po0.05, Student’s t-test. (c) μCT quantiﬁcation of total metaphyseal bone (including both cancellous and cortical bone). Note
that the parameters may not accurately reﬂect cancellous bone properties especially in CTRL and SOST mice due to the inclusion of both cancellous
and cortical bone in the analysis. *Po0.001, one-way ANOVA, n= 5 for CTRL and CKO, n= 6 for SOST, n= 7 for SOST;CKO. ANOVA, analysis of
variance; CTRL, control; SOST, sclerostin; 3D, three dimensional; μCT, micro-computed tomography.
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Figure 5. SOST expression is detected by immunoﬂuorescence in both cancellous and cortical bone in SOST; CKO mice. Immunostaining was
performed with non-immune IgG (a and e) or an antibody recognizing both murine and human sclerostin (b–d and f–h) on frozen sections of the
femur. Blue, nuclear staining by DAPI; BM, bone marrow; double-headed arrow, cortical bone; GF, growth plate; red, antibody staining against both
murine and human sclerostin; SOST, sclerostin.
Figure 4. SOST expression partially rescues cancellous but not cortical bone phenotype caused by Bmpr1a deletion. (a) Serum CTX-I assays, n= 3.
(b) Representative images of H&E stained sections of the distal femur at P33. Boxed regions are shown at a higher magniﬁcation in lower panels.
Arrow denotes accumulation of osteoblasts. (c and d) H&E staining (c) and quantiﬁcation of osteocyte density (d) in cortical bone of the femur at
P33. *Po0.001, two-way ANOVA, n= 3. (e) Representative images of calcein double labeling at periosteal surface in P33 littermate mice. (f)
Quantiﬁcation of MAR. *Po0.001, owo-way ANOVA, n= 3. ANOVA, analysis of variance; B, bone; M, marrow; SOST, sclerostin.
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the cross-sectional size of the cortical bone in the Bmpr1a
mutant mice (Figure 7b, CKO vs HBM; CKO, red arrows).
Quantitation of the tibial cortical bone at the tibia-ﬁbula
junction with μCT conﬁrmed that the cross-sectional size
(Tt. Ar) was similarly reduced by Bmpr1a deletion regardless
of the HBM allele (Figure 7c, left). However, the HBM allele
increased the cortical thickness (Ct. Ar) in both control and
Bmpr1a-deﬁcient mice, resulting similar decreases in the
marrow space (Ma. Ar) (Figure 7c, middle and right).
Therefore, although hyperactivation of Wnt signaling
promotes endosteal bone formation, it does not rescue
periosteal bone growth in the absence of Bmpr1a. To
establish further the efﬁcacy of the Lrp5 HBM allele in our
experimental setting, we analyzed the trabecular bone
phenotype in the HBM versus control mice. Histology
showed a clear increase in trabecular bone mass in both
primary and secondary ossiﬁcation centers of the tibia
(Figure 7d). Quantitative analyses of the proximal tibia
with μCT revealed a twofold increase in trabecular bone
mass (BV/TV) in HBM over control mice (Figure 7e). Overall,
based on this and our previous study, we propose a
model wherein Bmp signaling regulates cancellous bone
formation by both enhancing osteoblast activity and
restricting preosteoblast proliferation.10 The proliferation
constrain is at least partly mediated by the induction
of SOST in osteocytes but may also involve direct Bmp
action on the preosteoblasts (Figure 7f). The proposition of
direct inhibition of preosteoblast proliferation by Bmp is
based on the fact that hyperproliferation was not fully
corrected by the forced expression of SOST, but we cannot
rule out that the lack of a full rescue might be due to
the relatively low expression of SOST as previously
documented.28 We further propose that Bmp promotes
periosteal bone growth mainly through direct stimulation of
osteoblast activity largely independent of Wnt signaling
(Figure 7f).
Figure 6. Forced expression of SOST partially corrects hyperproliferation caused by Bmpr1a deletion. (a) Representative images of distal femur
labeled with EdU at P33. EdU signal is in green and DAPI nuclei staining in blue. (b) EdU labeling index over total cells in chondro-osseous junction.
(c) Representative images of Osx immunoﬂuorescence staining and EdU labeling at P33. Boxed regions in chondro-osseous junction below growth
plate are shown at a higher magniﬁcation in lower panels. EdU is in green and Osx in red; Arrows denote double positive cells. (d) EdU labeling
index among Osx+ preosteoblasts in chondro-osseous junction. (e) Negative control for Osx immunoﬂuorescence staining. A non-immuno IgG
detected no red signal on section from CTRL mouse. Region between dotted lines denotes chondro-osseous junction chosen for quantiﬁcation
[100 μm region immediately under growth plate (GP)]. GP: growth plate; M: marrow. *Po0.001, two-way ANOVA, n= 3. ANOVA, analysis of
variance; CTRL, control; SOST, sclerostin.
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DISCUSSION
We have investigated the role of Wnt signaling in mediat-
ing Bmpr1a function in bone. Speciﬁcally, we tested
whether genetic manipulation of Wnt signaling could
modify the bone phenotypes caused by Bmpr1a deletion,
namely excessive accrual of cancellous bone and
impaired periosteal growth of cortical bone. Whereas
forced expression of SOST partially rescued the cancellous
bone mass, a hyperactive form of Lrp5 did not ameliorate
the defect in periosteal bone growth in the Bmpr1a-
deﬁcient background. Mechanistically, SOST alleviated
the hyperproliferation of cancellous preosteoblasts caused
by Bmpr1a deletion. These results demonstrate that Bmp
signaling regulates bone formation through both Wnt-
dependent and -independent mechanisms.
It is worth noting that Bmp signaling appears to exert
different effects on endosteal versus periosteal bone
growth. Although the deletion of Bmpr1a notably restricted
periosteal bone growth throughout the tibia, it did not
reduce the total amount of cortical bone. In calcein
labeling experiments, we frequently observed double-
labeled surfaces at the endosteum of the diaphysis in the
CKO but not the wild-type mice at P33, indicating an
increase of active osteoblasts over the quiescent lining
cells on the endosteal bone surface in the absence of
Bmpr1a. The reasons for the increase in active endosteal
Figure 7. High bone mass Lrp5 mutant allele does not restore periosteal bone growth in Bmpr1a-deﬁcient mice. (a) Mating scheme. (b)
Representative X-ray images of hindlimbs of littermate mice at P33. f: femur; ﬁ: ﬁbula; t: tibia. Arrows denote smaller diameter in the proximal femur
speciﬁc to CKO and HBM;CKO mice. Discs mark region of tibia (tibia-ﬁbula junction) analyzed by μCT in (c). (c) Quantiﬁcation of cortical bone
parameters by μCT at region of tibia marked by disc in B. *Po0.01, two-way ANOVA, n= 4. (d) Representative images for H&E staining of
longitudinal sections through the proximal tibia. Note more bone in trabecular region (TB) and secondary ossiﬁcation center (2°) in HBM than CTRL.
(e) Quantiﬁcation of trabecular bone parameters by μCT. (f) Model for Bmp signaling in osteoblast lineage cells. Bmp signaling via Bmpr1a directly
promotes osteoblast activity in both trabecular and periosteal bone. Bmp also acts on osteocytes to induce SOST that in turn suppresses preosteoblast
proliferation in trabecular bone region. On the other hand, production of periosteal osteoblasts is not altered by increased Wnt signaling. Trabecular
versus periosteal osteoblast lineage is depicted in green versus blue. Red arrow and blocked arrow indicate stimulation and inhibition, respectively.
Dashed line indicates potential action. ANOVA, analysis of variance; CTRL, control; OB, osteoblast; OC, osteocyte; PreOB, preosteoblast;
2°, secondary ossiﬁcation center; μCT, micro-computed tomography.
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osteoblasts however, are currently unclear. Aside from the
potential direct effects of Bmpr1a deletion, we suspect
that an increase in mechanical stress due to the reduced
cross-sectional bone size may prolong the productive life
span of endosteal osteoblasts. The mechanical stress
response model is appealing as it helps to explain the
normal, but not excessive cortical bone mass in the CKO
mice; this is an intriguing distinction from the HBMmice that
possess an abnormally high amount of cortical bone mass
even though the overall sectional size of the bone is normal
at P33 (Figure 7c). Regardless of the exact mechanism,
hyperactive Wnt signaling by the mutant Lrp5 stimulated
excessive endosteal bone formation regardless of Bmpr1a.
Thus, whereas Bmpr1a is epistatic to Wnt in stimulating
periosteal bone growth, the opposite appears to be true in
regards to endosteal bone formation.
The study has also revealed different responses by
cancellous versus cortical bone to perturbation of Wnt
signaling. Expression of SOST or the mutant Lrp5 reduced or
increased cancellous bone mass, respectively, demon-
strating a stimulatory effect of Wnt signaling in the
cancellous bone compartment. In contrast, neither manip-
ulation had any effect on the cross-sectional size of the
long bones by postnatal 33 days, indicating the relative
independence of periosteal bone growth on the level of
Wnt signaling. As others have reported that the same
mutant Lrp5 (A214V) leads to bigger bone sizes in
4-month-old mice, bone expansion at the periosteum
may be more sensitive to hyperactive Wnt signaling in
adults than in young animals.29 Recently, deletion of Sfrp4,
a secreted antagonist of Wnt proteins, was shown to
increase cancellous bone volume but reduce cortical
thickness while expanding the cross-sectional size,
perhaps though compartment-speciﬁc regulation of Bmp
signaling.30 Further studies are warranted to elucidate fully
the molecular basis for site-speciﬁc effects of Wnt pertur-
bation on bone resorption and formation.
We have focused our study on the regulation of bone
formation by Bmp signaling. Others have reported a similar
increase in cancellous bone mass following deletion of
Bmpr1a with Col1-CreER or Dmp1-Cre but attributed the
phenotypemostly to the suppression of bone resorption.19–21
We, however, have not detected a signiﬁcant difference in
CTX-I levels between wild-type and Dmp1-Cre; Bmpr1af/f
(CKO) littermates at P33 (ref. 10) (this study). We are mindful,
however, that the sample size in both studies was limited
(n=3) and analyses of more mice might reveal differences
between the genotypes. On the other hand, it is possible
that the status of bone resorption in the mutant mice
changes with age, as others noted a decrease of serum
CTX-I levels in the CKO mice at 16 weeks of age.21 Of note,
deletion of Bmpr1a or Smad4 in mature osteoblasts
(Og2-Cre) also led to a decrease in bone resorption most
notable in the aged mice.17,31 Thus, whereas increased
osteoblast number appears to drive the excessive
cancellous bone mass early in life in the CKO mice, a
decrease in bone resorption could exacerbate the
phenotype in aged mice.
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